Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,292.70 -25.53 -0.17%
S&P 500 1,649.71 -2.10 -0.13%
Nasdaq 3,475.31 -6.87 -0.20%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Celera Corp

CRA:US

Acquired

Celera Corp (CRA:US) was acquired by DGX:US


Company Profile

Celera Corporation is diagnostics company that delivers personalized disease management through a combination of products and services. The Company operates a clinical laboratory that provides testing services and develops, manufactures, and oversees the commercialization of molecular diagnostic products.

Advertisement
sec ||= nil